Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism

NCT ID: NCT01803594

Last Updated: 2022-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-08-31

Study Completion Date

2015-03-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study involves measuring subject's blood lipid responses after they consume a mixture of dietary fats of marine and dairy origin and vitamin supplements mixed into a milkshake, on three separate days. The investigators hope to learn more about how different food ingredients influence the metabolism HDL in individuals with low blood levels of HDL cholesterol.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study a partial randomized crossover study designed to determine how consumption of bioactive dietary ingredients in various combinations on three separate test days influences postprandial lipoprotein metabolism in participants with low circulating HDL-cholesterol.

The dietary ingredients include:

Dairy phospholipids(PC700); krill oil (K); lutein (L); and Niacin

Eligible participants will arrive to the University of California Davis (UC Davis), Ragle Human Nutrition Center on the morning of each test day after a 10-12-hr overnight fast. Upon arrival participants will fill out a questionnaire about their dietary and medication intakes and physical activity for the past 72 hours to ensure compliance. Compliant participants' weight and blood pressure will be measured and a fasting blood draw will be taken before participants consume their test meal in the form of a milkshake (control, PC700KL, PC700KL + Niacin). On each test day, participants will be given only this meal and provided with ample supply of bottled water.

Participants will only consume this test meal and water freely for the duration of the test day. Blood will be drawn serially at 2 and 4 hours postprandially. Participants will also be asked to provide 3 urine samples throughout the study: before and 2, and 4 hours after consumption of the milkshake. Participants will be tested on two additional separate test days after the first day separated by a two-week washout. The first two test days will be randomized, however the third test day will always contain niacin in order to require participants remain at Ragle for the first two hours of the study to monitor niacin flushing reactions. Participants have the option of participating in two out of three of the test days if they wish to exclude themselves from the niacin test day.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyslipidemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Shake

Each shake delivers 30% of each participant's calculated energy expenditure and provides 45% energy as fat, 40% energy as carbohydrate and 15% energy as protein. The shake contains whipping cream, frozen fruit, glucose polymer, and protein powder.

Group Type PLACEBO_COMPARATOR

Control

Intervention Type OTHER

Control shake without dietary supplements

PC700, Krill Oil, and Lutein

Each shake delivers 30% of each participant's calculated energy expenditure and provides 45% energy as fat, 40% energy as carbohydrate and 15% energy as protein. The shake contains whipping cream, frozen fruit, glucose polymer, and protein powder. Fifty percent of the fat is made up of PC700. Additionally, 3.0g Krill oil and 40mg of lutein capsules are swallowed with water.

Neptune Krill Oil capsules (Nutrigold); Lutein capsules (Jarrow Formulas); PC700 = dairy lipids (Fonterra brand)

Group Type ACTIVE_COMPARATOR

Krill Oil

Intervention Type DIETARY_SUPPLEMENT

Neptune Krill Oil Gold

Lutein

Intervention Type DIETARY_SUPPLEMENT

Jarrow Formulas

Dairy phospholipids

Intervention Type DIETARY_SUPPLEMENT

PC700 manufactured by Fonterra

PC700, Krill Oil, Lutein, and Niacin

Each shake delivers 30% of each participant's calculated energy expenditure and provides 45% energy as fat, 40% energy as carbohydrate and 15% energy as protein. The shake contains whipping cream, frozen fruit, glucose polymer, and protein powder. Fifty percent of the fat is made up of PC700. Additionally, 3.0g Krill oil and 40mg of lutein capsules are swallowed with water. Nicotinic acid was added to each shake prior to consumption at a doses 5mg/kg of body weight.

Neptune Krill Oil capsules (Nutrigold); Lutein capsules (Jarrow Formulas); PC700 (Fonterra); Nicotinic acid (Natures Way)

Group Type ACTIVE_COMPARATOR

Krill Oil

Intervention Type DIETARY_SUPPLEMENT

Neptune Krill Oil Gold

Lutein

Intervention Type DIETARY_SUPPLEMENT

Jarrow Formulas

Nicotinic acid

Intervention Type DIETARY_SUPPLEMENT

Natures Way

Dairy phospholipids

Intervention Type DIETARY_SUPPLEMENT

PC700 manufactured by Fonterra

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Krill Oil

Neptune Krill Oil Gold

Intervention Type DIETARY_SUPPLEMENT

Lutein

Jarrow Formulas

Intervention Type DIETARY_SUPPLEMENT

Nicotinic acid

Natures Way

Intervention Type DIETARY_SUPPLEMENT

Dairy phospholipids

PC700 manufactured by Fonterra

Intervention Type DIETARY_SUPPLEMENT

Control

Control shake without dietary supplements

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-65 years
* Plasma HDL cholesterol (Less than 50 mg/dL)

Exclusion Criteria

* History of gastrointestinal disorders like Crohns disease, colitis, irritable bowel syndrome
* History of cardiovascular events: stroke, heart attack, cardiac arrhythmia
* History of peptic ulcers, gastritis
* History of gout
* History of being under care of any psychiatric conditions (schizophrenia and depression associated with response to niacin)
* Cancer
* Type 1 or 2 diabetes
* Known presence of significant metabolic disease which could impact results of study (hepatic, renal disease)
* Low blood pressure (defined as 3 consecutive readings below 100/60 mmHg at screening)
* Self report skin sensitivities; self report to rash easily
* Self report to hot flashes currently experience due to menopause
* Hypersensitivity to niacin
* Muscle disorders such as myasthenia gravis
* Pending surgery within the next 3 months
* Known allergy to study food (shellfish, fish, nut, soy)
* Known intolerance to study food (lactose intolerance)
* More than 1 serving of fish per week
* Intake of anti-inflammatory supplemental fish, krill, borage, flax, and primrose seed oils within the last 12 weeks
* Intake of dietary supplements consisting of concentrated soy isoflavones, resveratrol, other dietary polyphenols identified as modulators of lipids within the last 12 weeks
* Intake of more than 20 mg of lutein and zeaxanthin per week
* Intake of nicotinic acid (niacin) within the last 12 weeks
* Intake of anti-coagulants, blood pressure or heart medications within the last 12 weeks
* Plan to become pregnant in next 6 months
* Recent initiation (past 4 weeks) of exercise program
* Use of tobacco products
* Excessive alcohol consumption (2 drinks/day for men and 1 drink/day for women)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unilever R&D

INDUSTRY

Sponsor Role collaborator

University of California, Davis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer T Smilowitz, PhD

Role: PRINCIPAL_INVESTIGATOR

University of California, Davis

J. Bruce German, PhD

Role: PRINCIPAL_INVESTIGATOR

University of California, Davis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UC Davis, Ragle Human Nutrition Center

Davis, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Dalbeth N, Gracey E, Pool B, Callon K, McQueen FM, Cornish J, MacGibbon A, Palmano K. Identification of dairy fractions with anti-inflammatory properties in models of acute gout. Ann Rheum Dis. 2010 Apr;69(4):766-9. doi: 10.1136/ard.2009.113290. Epub 2009 Aug 26.

Reference Type BACKGROUND
PMID: 19713204 (View on PubMed)

Snow DR, Ward RE, Olsen A, Jimenez-Flores R, Hintze KJ. Membrane-rich milk fat diet provides protection against gastrointestinal leakiness in mice treated with lipopolysaccharide. J Dairy Sci. 2011 May;94(5):2201-12. doi: 10.3168/jds.2010-3886.

Reference Type BACKGROUND
PMID: 21524510 (View on PubMed)

Mozaffarian D, Rimm EB, Herrington DM. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr. 2004 Nov;80(5):1175-84. doi: 10.1093/ajcn/80.5.1175.

Reference Type BACKGROUND
PMID: 15531663 (View on PubMed)

Tholstrup T, Vessby B, Sandstrom B. Difference in effect of myristic and stearic acid on plasma HDL cholesterol within 24 h in young men. Eur J Clin Nutr. 2003 Jun;57(6):735-42. doi: 10.1038/sj.ejcn.1601605.

Reference Type BACKGROUND
PMID: 12792657 (View on PubMed)

Bunea R, El Farrah K, Deutsch L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev. 2004 Dec;9(4):420-8.

Reference Type BACKGROUND
PMID: 15656713 (View on PubMed)

Ribaya-Mercado JD, Blumberg JB. Lutein and zeaxanthin and their potential roles in disease prevention. J Am Coll Nutr. 2004 Dec;23(6 Suppl):567S-587S. doi: 10.1080/07315724.2004.10719427.

Reference Type BACKGROUND
PMID: 15640510 (View on PubMed)

Kiokias S, Gordon MH. Dietary supplementation with a natural carotenoid mixture decreases oxidative stress. Eur J Clin Nutr. 2003 Sep;57(9):1135-40. doi: 10.1038/sj.ejcn.1601655.

Reference Type BACKGROUND
PMID: 12947433 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://ffhi.ucdavis.edu/human-studies/hdl-metabolic-milkshake

More information about the research is available on the UC Davis Foods for Health Institute's website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

264254

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.